Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem - Empfehlungen des ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC)

Translated title of the contribution: Position paper: Recommendations on the use of omalizumab in chronic rhinosinusitis with nasal polyps (CRSwNP) in the German healthcare system - Recommendations of the Medical Association of German Allergologists (AeDA) and the Working Groups on Clinical Immunology, Allergology and Environmental Medicine and Rhinology and Rhinosurgery of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC)

L. Klimek, U. Förster-Ruhrmann, A. G. Beule, A. M. Chaker, J. Hagemann, T. Huppertz, T. K. Hoffmann, S. Dazert, T. Deitmer, H. Olze, S. Strieth, H. Wrede, W. Schlenter, H. J. Welkoborsky, B. Wollenberg, S. Becker, C. Rudack, M. Wagenmann, C. Bergmann, C. Bachert

Research output: Contribution to journalArticlepeer-review

8 Scopus citations
Translated title of the contributionPosition paper: Recommendations on the use of omalizumab in chronic rhinosinusitis with nasal polyps (CRSwNP) in the German healthcare system - Recommendations of the Medical Association of German Allergologists (AeDA) and the Working Groups on Clinical Immunology, Allergology and Environmental Medicine and Rhinology and Rhinosurgery of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKHC)
Original languageGerman
Pages (from-to)952-963
Number of pages12
JournalLaryngo- Rhino- Otologie
Volume100
Issue number12
DOIs
StatePublished - 1 Dec 2021
Externally publishedYes

Cite this